From the earliest stage of lung development, there is an accompanying blood circulation. This formation of vessels occurs until the 17th week of gestation when all pre-acinar airways and their accompanying arteries and veins are formed, ending the pseudoglandular stage. At this point, there is little undifferentiated mesenchyme left between the structures. In later lung development, as the alveoli multiply, new capillaries form by angiogenesis. As blood vessels increase in size, they develop a muscle wall that is relatively thick during fetal life and shows a rapid reduction after birth [1].At the present time, there is a consensus about the antenatal use of corticosteroid to reduce the respiratory distress syndrome and neonatal mortality among preterm newborns [2]. The corticosteroid therapy has been used to accelerate fetal lung maturation, but the real mechanisms are yet to be understood.Doppler echocardiography technique has shown to be highly accurate in fetal hemodynamic analysis, what includes also the study of fetal pulmonary vessels [3]. The reduction in pulmonary artery flow resistance observed by Doppler echocardiography could explain the mechanism of action for corticosteroid to accelerate fetal lung maturation, and it could constitute an important clinical marker of this therapy efficacy.The objective of this prospective study was to describe the changes in fetal pulmonary artery (PA) blood flow, observed during Doppler echocardiography exams after maternal corticosteroid therapy. This preliminary study comprised five pregnant women with pregnancy ranging from 29 to 33 weeks. All women received two doses of 0020-7292/$ -see front matter D